NO20062262L - Cykloalkylderivater av 3-hydroksy-4-pyridinoner - Google Patents

Cykloalkylderivater av 3-hydroksy-4-pyridinoner

Info

Publication number
NO20062262L
NO20062262L NO20062262A NO20062262A NO20062262L NO 20062262 L NO20062262 L NO 20062262L NO 20062262 A NO20062262 A NO 20062262A NO 20062262 A NO20062262 A NO 20062262A NO 20062262 L NO20062262 L NO 20062262L
Authority
NO
Norway
Prior art keywords
alkyl
cycloalkyl
group
iron
proviso
Prior art date
Application number
NO20062262A
Other languages
English (en)
Inventor
Tim Fat Tam
Michael Spino
Wanren Li
Yingsheng Wang
Yanqing Zhao
Birenkumar Hasmukhbhai Shah
Original Assignee
Apotex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotex Inc filed Critical Apotex Inc
Publication of NO20062262L publication Critical patent/NO20062262L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer et cykloalkyl-derivat av 3-hydroksy-4-pyridinon som er anvendelige for chelatering av metallioner, så som jern. Dens fremstilling og anvendelse er beskrevet. Spesielt angår oppfinnelsen fjerning av jern i kjemiske og biologiske systemer, omfattende chelaterende midler som har formelen (I); hvor R1 er X, med det forbehold at R2 er Y; eller R1 er T, med det forbehold at R2 er W; eller R1 er X, med det forbehold at R2R5N sammen danner en heterocyklisk ring valgt fra piperidinyl, morfolinyl, pyrrolidinyl eller piperazinyl, hvor gruppen piperidinyl, morfolinyl, pyrrolidinyl eller piperazinyl enten er usubstituert eller substituert med én til tre C1- til C6-alkylgrupper. X er C3-C6-cykloalkyl; Y er valgt fra gruppen bestående av C1- til C6-cykloalkyl; C1- til C6-alkyl og C1- til C6-alkyl monosubstituert med et C3-C6-cykloalkyl; T er C1- til C6-alkyl; W er C3-C6-cykloalkyl; R3 er valgt fra gruppen bestående av hydrogen og d- til C6-alkyl; R4 er valgt fra gruppen bestående av hydrogen og C1- til C6-alkyl; R5 er valgt fra gruppen bestående av hydrogen og C1- til C6-alkyl; og dens farmasøytisk akseptabelt salt derav. Farmasøytiske preparater av slike forbindelser er anvendelige til fjerning av overskudd av jern i kroppen hos pasienter med jernbelastningssykdommer.
NO20062262A 2003-11-20 2006-05-19 Cykloalkylderivater av 3-hydroksy-4-pyridinoner NO20062262L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ529657A NZ529657A (en) 2003-11-20 2003-11-20 Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones
PCT/CA2004/001986 WO2005049609A1 (en) 2003-11-20 2004-11-18 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones

Publications (1)

Publication Number Publication Date
NO20062262L true NO20062262L (no) 2006-08-11

Family

ID=31987701

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062262A NO20062262L (no) 2003-11-20 2006-05-19 Cykloalkylderivater av 3-hydroksy-4-pyridinoner

Country Status (16)

Country Link
US (2) US7410985B2 (no)
EP (1) EP1687298B1 (no)
KR (1) KR101166113B1 (no)
CN (1) CN100448873C (no)
AU (2) AU2004291184B2 (no)
BR (1) BRPI0416703A (no)
CA (1) CA2546781C (no)
IL (1) IL175654A (no)
MX (1) MXPA06005594A (no)
NO (1) NO20062262L (no)
NZ (1) NZ529657A (no)
RU (1) RU2345992C2 (no)
TN (1) TNSN06142A1 (no)
UA (1) UA84178C2 (no)
WO (1) WO2005049609A1 (no)
ZA (1) ZA200604998B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2488034C (en) 2004-11-19 2009-10-06 Apotex Inc. Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
DE102006043929B4 (de) * 2006-09-14 2016-10-06 Spawnt Private S.À.R.L. Verfahren zur Herstellung von festen Polysilanmischungen
EP2320909B8 (en) * 2008-07-25 2016-03-30 VIIV Healthcare Company Chemical compounds
CN101975767B (zh) * 2010-08-13 2012-12-05 同济大学 一种测定水环境中溶解性有机物与金属离子结合潜势的方法
US10064858B2 (en) * 2011-01-31 2018-09-04 The United States Of America, As Represented By The Secretary Of The Army Methods and compositions for treating bacterial infections with iron chelators
CN102603964B (zh) * 2012-01-15 2014-03-05 浙江工商大学 水溶性聚合物铁螯合剂及其制备方法和用途
CN105030819B (zh) * 2015-07-06 2019-04-05 中国科学技术大学 一种3-羟基-4-吡啶酮类高分子铁螯合剂的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB9217099D0 (en) * 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
ES2244967T3 (es) * 1995-09-29 2005-12-16 Novartis Ag Nuevas hidroxipiridinonas.
US6448273B1 (en) * 1997-05-29 2002-09-10 Btg International Limited Orally active iron (III) chelators
GB9711093D0 (en) * 1997-05-29 1997-07-23 British Tech Group Novel orally active iron (III) chelators
US6488273B2 (en) 2001-04-20 2002-12-03 Btm Corporation Powered pivot unit
US6426418B1 (en) * 2001-11-02 2002-07-30 Apotex, Inc. Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
CA2379370A1 (en) 2002-03-28 2003-09-28 Apotex Inc. Carboxylic acid derivatives of 3-hydroxy-4-oxo-1,4-dihydropyridine as iron chelators

Also Published As

Publication number Publication date
EP1687298A4 (en) 2007-10-17
US7410985B2 (en) 2008-08-12
CN1926135A (zh) 2007-03-07
MXPA06005594A (es) 2006-12-19
TNSN06142A1 (en) 2007-11-15
CA2546781A1 (en) 2005-06-02
UA84178C2 (en) 2008-09-25
EP1687298B1 (en) 2012-12-26
CA2546781C (en) 2012-05-15
KR101166113B1 (ko) 2012-07-27
KR20060096155A (ko) 2006-09-07
AU2004291184B2 (en) 2010-08-26
AU2004291184A1 (en) 2005-06-02
RU2006121547A (ru) 2007-12-27
BRPI0416703A (pt) 2007-01-16
IL175654A0 (en) 2006-09-05
NZ529657A (en) 2004-07-30
ZA200604998B (en) 2007-09-26
US20070082904A1 (en) 2007-04-12
AU2010246323A1 (en) 2010-12-09
CN100448873C (zh) 2009-01-07
IL175654A (en) 2011-10-31
US20090170850A1 (en) 2009-07-02
US8097624B2 (en) 2012-01-17
RU2345992C2 (ru) 2009-02-10
WO2005049609A1 (en) 2005-06-02
EP1687298A1 (en) 2006-08-09

Similar Documents

Publication Publication Date Title
NO20062262L (no) Cykloalkylderivater av 3-hydroksy-4-pyridinoner
NO20051165L (no) Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
NO20073357L (no) 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien
NO20055316L (no) Nye heterocykliske forbindelser som er nyttige ved behandling av inflammatoriske og allergiske forstyrrelser, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger som inneholder slike
NO20062633L (no) Pyrazolderivater som proteinkinasemodulatorer
NO20063446L (no) Tiazolderivater
AU2003215753A1 (en) Imidazopyridine derivatives as kinase inhibitors
NO20083542L (no) Nye kumarinderivater med antitumoraktivitet
WO2007122634A3 (en) Pyrimidinediones as tyrosine kinase inhibitors
NO20053133L (no) Kjemiske forbindelser.
MXPA04007470A (es) Piridinonas sustituidas.
NO20070557L (no) Ftalazinderivater som PARP-inhibitorer
DE69406649T2 (de) N-alkyl-2-substituierte atp-analoge
HUP0401009A2 (hu) 5-Hidroxitriptamin-6-ligandumokként alkalmazható 1-aril- vagy 1- alkil-szulfonilbenzazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0301336A2 (hu) Réztartalmú amin-oxidázok inhibitorai és alkalmazásuk gyógyszerkészítmények előállítására
DK611686A (da) Pyrazolinderivater, fremgangsmaade til fremstilling deraf og deres anvendelse som middel med insekticid og akaricid virkning
EP1396493A4 (en) HETEROCYCLIC COMPOUNDS
NO20060314L (no) Nicotinamid-derivater anvendbare som PDE4-inhibitorer
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
WO2001014330A3 (en) Phenylpiperazines as serotonin reuptake inhibitors
NO20061045L (no) Imidazolderivater
ATE300541T1 (de) Pyrazolopyridinderivate
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
HUP0401575A2 (hu) Új vinil-karbonsav-származékok és ezek alkalmazása cukorbetegség ellen és ezeket tartalmazó gyógyszerkészítmények
SE0200919D0 (sv) Chemical compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application